Table 1.
RT-qPCR and qPCR assay oligonucleotides and calibration model performance metrics.
Viral target | Name | Sequence (5′ → 3′) | Y-intercept range | R2 range | Slope range | Amplification efficiency | References |
---|---|---|---|---|---|---|---|
| |||||||
Adenovirus | P: JTVXP | FAM-CTGGTGCAGTTCGCCCGTGCCA-TAMRA | 40.254–42.307 | 0.990–0.997 | −3.517 to −3.305 | 0.955 ± 0.027 | (Jothikumar et al., 2005a) |
F: JTVXF | GGACGCCTCGGAGTACCTGAG | ||||||
R: JTVXR | ACIGTGGGGTTTCTGAACTTGTT | ||||||
Norovirus GI | P: NV1LCpr | FAM-TGGACAGGAGAYCGCRATCT-TAMRA | 37.987–39.580 | 0.990–0.998 | − 3.427 to−3.279 | 0.981 ± 0.020 | (da Silva et al., 2007; Svraka et al., 2007) |
F: QNIF4 | CGCTGGATGCGNTTCCAT | ||||||
R: NV1LCR | CCTTAGACGCCATCATCATTTAC | ||||||
Norovirus GII | P: QNIFS | FAM-AGCACGTGGGAGGGCGATCG-TAMRA | 35.852–37.826 | 0.993–0.998 | − 3.533 to −3.145 | 0.974 ± 0.044 | (Loisy et al., 2005; Jothikumar et al., 2005b) |
F: QNIF2d | ATGTTCAGRTGGATGAGRTTCTCWGA | ||||||
R: COG2R | TCGACGCCATCTTCATTCACA | ||||||
Hepatitis G | P: HepG-P | VIC-TCACCCATCCACCACCT-MGBNFQ | N/A | N/A | N/A | N/A | (Cashdollar et al., 2013) |
F: HepG-F | GCAAGCCCCAGAAACCG | ||||||
R: HepG-R | CAAGATGACCGGGATTTACGA | ||||||
CrAssphage 056 | P: 056P1 | FAM-AATAACGATTTACGTGATGTAAC-MGBNFQ | 40.452–42.307 | 0.987–0.996 | −3.514 to − 3.397 | 0.951 ± 0.015 | (Farkas et al., 2019) |
F: 056F1 | CAGAAGTACAAACTCCTAAAAAACGTA | ||||||
R: 056R1 | GATGACCAATAAACAAGCCATTA | ||||||
Human Polyomavirus | P: KGJ3 | FAM-TCATCACTGGCAAACAT-MG | 38.645–40.63 | 0.985–0.99 | −3.540 to 3.34 | 0.957 ± 0.027 | (McQuaig et al., 2006) |
F: SM2 | AGTCTTTAGGGTCTTCTACCTTT | ||||||
R: P6 | GGTGCCAACCTATGGAACAG |